For most men with clinically confirmed low testosterone, testosterone replacement therapy is considered safe but that qualifier matters more than the headline. Safety here is conditional. It depends on whether the diagnosis was done properly, how the therapy is delivered, and whether regular bloodwork is part of ongoing care. When those conditions are met, the evidence supports TRT as a manageable and effective treatment. When they aren’t, risk accumulates fast.

The medical conversation around TRT has changed significantly in recent years. Earlier studies created real uncertainty about cardiovascular risk. More recent, better-designed trials have largely resolved that debate, giving men considering TRT today a much clearer picture than was available a decade ago.

What Major Clinical Trials Actually Found

The clearest answer came in 2023, when the TRAVERSE trial published in the New England Journal of Medicine studied testosterone replacement in men with confirmed hypogonadism who also had existing cardiovascular disease or significant cardiac risk factors. The result was that TRT was non-inferior to placebo for major adverse cardiovascular events. Heart attacks and strokes were not more common in men who received testosterone than in men who received a placebo.

That matters because earlier observational studies had raised cardiovascular flags, and that uncertainty made many physicians cautious about prescribing. The TRAVERSE trial’s design randomized, controlled, large sample carries far more weight than those earlier studies. For men with confirmed low testosterone and even significant cardiac history, the current data does not support an elevated risk of heart attack.

The trial did identify two elevated risks that shouldn’t be dismissed: higher rates of atrial fibrillation and venous thromboembolism (deep vein blood clots). These are specific, documented complications that strengthen the case for proper monitoring, especially in men with prior clotting history or arrhythmia.

The Risks That Are Real and Worth Taking Seriously

Erythrocytosis elevated red blood cell count is the most consistent dose-related risk of TRT. Testosterone signals the body to produce more red blood cells. When that count rises too high, blood thickens and clotting risk increases. Injectable forms carry the highest likelihood of pushing hematocrit above safe thresholds because of hormone peaks shortly after injection. This risk is covered in detail in the guide on high hematocrit on TRT.

Prostate growth is the concern most men raise first. Testosterone does not cause prostate cancer — the evidence for that causal link is weak and has not held up in controlled studies but it can stimulate growth of existing prostate tissue, which matters for men with benign prostatic hyperplasia. PSA levels should be tested before starting and tracked throughout. A detailed breakdown of the research lives in TRT and prostate health.

Fertility is the risk men in their 30s and early 40s most often underestimate. Exogenous testosterone suppresses the pituitary signaling that drives sperm production. Sperm counts often fall significantly. This effect is usually reversible after stopping TRT but can take months to years to resolve. The full tradeoff is explained in TRT and fertility.

Who Should Not Use TRT

Active prostate cancer or breast cancer is a hard contraindication — testosterone can drive growth in hormone-sensitive tumors. Recent heart attack or stroke, uncontrolled heart failure, and untreated severe sleep apnea are other situations requiring thorough specialist review before starting. Men with elevated hematocrit before treatment are also poor candidates until the underlying cause is identified.

Men who want to father children in the near term should explore alternatives first. Clomiphene and enclomiphene stimulate the body’s own testosterone production axis rather than replacing the hormone externally, raising levels while preserving sperm production.

Why Proper Diagnosis Matters Before Anything Else

TRT’s favorable safety data applies to men who genuinely have low testosterone. The picture changes when it’s prescribed to men who don’t — and that happens more than it should, given how accessible online testosterone prescriptions have become.

A proper evaluation requires at least two morning testosterone tests, since levels are highest early in the day and vary day to day. A single value below 300 ng/dL is not automatically diagnostic. Symptoms must also be consistent with hypogonadism fatigue, reduced libido, loss of muscle mass, mood shifts, difficulty concentrating. Conditions that mimic those symptoms, including thyroid dysfunction, sleep apnea, depression, and obesity, should be ruled out or treated first.

Understanding the difference between total and free testosterone also matters, since it’s the free fraction that’s biologically active and tells a more complete story when total levels are borderline. That distinction is explained in the guide on free vs total testosterone.

How Delivery Method Changes the Safety Picture

TRT isn’t a single drug it’s a therapy delivered through several different mechanisms, each with its own risk profile.

Injectable testosterone, typically testosterone cypionate or enanthate given intramuscularly every one to two weeks, is the most widely used form in the US. It’s cost-effective and well-studied. The tradeoff is that it produces peaks and troughs in hormone levels some men experience mood fluctuations — and carries the highest hematocrit risk because of those peaks.

Gels and creams applied daily produce more stable levels and are less likely to spike red blood cell counts. The main practical concern is transference — testosterone gel can transfer to a partner or child through skin contact, causing unintended hormonal exposure.

Subcutaneous pellets, implanted every three to six months, offer genuine convenience but come with a significant limitation: once inserted, the dose can’t be adjusted. If levels run too high or a man reacts poorly, there’s no rapid correction.

Understanding how delivery method affects risk is part of making a sound decision before starting. A full breakdown of TRT side effects by type and method is worth reviewing.

What Ongoing Monitoring Looks Like

The difference between TRT done well and TRT done badly often comes down to follow-up care. Most of the therapy’s risks — elevated hematocrit, rising PSA, worsening atrial fibrillation are detectable early and manageable when caught. Left undetected, they compound.

Standard care includes a complete blood count and PSA check at three months after initiating treatment, then every six to twelve months. Testosterone levels should confirm the patient is maintaining a therapeutic range, typically 500 to 800 ng/dL, rather than running supra-physiologic levels that increase side-effect risk. For injectable testosterone, checking at the trough just before the next injection gives the most accurate read of baseline levels.

Research published by the National Institutes of Health finds that adverse outcomes in TRT are concentrated in inadequately monitored populations men receiving prescriptions without regular follow-up. Monitoring isn’t optional care; it’s what makes the therapy safe.

Finding Safe TRT Care in New York City

New York City has no shortage of TRT providers, which means the quality spread is wide. The markers of good care are not subtle. A legitimate provider runs comprehensive bloodwork before prescribing total testosterone, free testosterone, LH, FSH, PSA, complete blood count, and a metabolic panel — and continues monitoring at regular intervals thereafter.

Telehealth TRT is legal and widely available in New York State and works as a legitimate care model for men with demanding schedules, which is a common reality across Manhattan, Brooklyn, Queens, the Bronx, and Staten Island. Most telehealth providers partner with labs like LabCorp or Quest, which have locations throughout all five boroughs, so a blood draw is rarely more than a subway ride away. What matters is that the provider applies the same diagnostic and monitoring standards as in-person care — not just convenience.

Long-term outcome research, including data tracking men across a decade of therapy, shows sustained clinical benefit and an acceptable risk profile in appropriately selected patients under proper supervision. TRT’s risks are real, specific, and manageable. What makes them manageable is monitoring.

Frequently Asked Questions

Is testosterone replacement therapy safe for men over 50?

Generally yes, for men with confirmed hypogonadism and no major contraindications. The TRAVERSE trial specifically included older men with cardiovascular risk factors and found no increased rate of heart attack or stroke. Prostate health and hematocrit warrant more frequent monitoring in this age group, since both become more sensitive with age, but neither rules TRT out.

Can TRT cause a heart attack?

The 2023 TRAVERSE trial, published in the New England Journal of Medicine, found no increased risk of heart attack or stroke in men with confirmed low testosterone receiving TRT compared to placebo. Earlier concerns came largely from observational studies with significant design flaws. The cardiovascular risks with stronger current evidence are atrial fibrillation and venous blood clots, not myocardial infarction.

Does testosterone replacement therapy cause prostate cancer?

The evidence for a causal link between TRT and prostate cancer remains weak and has not been confirmed in controlled trials. However, testosterone can accelerate growth in existing prostate tumors, making TRT inappropriate for men with active prostate cancer. PSA monitoring before starting and throughout treatment is the standard early-warning system for prostate changes.

How long is it safe to stay on TRT?

There is no established upper time limit, provided bloodwork stays stable and monitoring continues. Men have used TRT for a decade or longer without increasing their adverse event rate when follow-up care is maintained. TRT is typically a long-term commitment, and the decision to continue should be reassessed periodically with a physician.

What happens when TRT is stopped?

Stopping TRT usually causes testosterone to return toward its pre-treatment baseline over weeks to months, as the pituitary and testes resume natural signaling once exogenous testosterone clears the system. Symptoms of low testosterone — fatigue, low libido, mood changes typically return. For men stopping because of fertility concerns, sperm production usually recovers, though the timeline varies. More detail lives in what happens when you stop TRT.